Velsera | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Velsera | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Updated November 25, 2025
Public ProfileLinkedInLinkedIn Profile

Velsera is a global healthcare technology company established in 2023 through the merger of Seven Bridges, PierianDx, and UgenTec.

Employees182
Revenue$50M

Industry & Market

Primary Industry
research
Location
Boston, Massachusetts, United States

Funding Information

Annual Revenue
$50,000,000
Publicly traded company

Headcount Distribution

Total Employees
182
Departments
19

By Department

Department Breakdown

Engineering
Support
Operations
Product Management
Business Development
Education
Others

Keywords & Focus Areas

biotechnology researchworkflow automationcloud-based softwareconsultinghealthcare analyticsvariant interpretation knowledge baseregulatory reportingpharma researchdata interoperabilitymulti-omics integrationbiomedical dataregulatory pathway supportclinical variant databasesmulti-omics assay scalinglongitudinal clinicogenomic datangs analysisprecision medicinedata sharing platformresearch collaborationgenomic insights+10 more
30 total keywords

Overview

Velsera is a global healthcare technology company established in 2023 through the merger of Seven Bridges, PierianDx, and UgenTec. The company operates in the US, Europe, and Asia, focusing on advancing precision medicine with a universal software platform that connects clinical care and scientific discovery.

The company provides advanced software solutions and expert services aimed at accelerating the discovery, development, and delivery of precision medicine. Its flagship product, the Clinical Genomics Workspace (CGW) platform, has been enhanced to CGW Plus, supporting workflows for variant quality assessment and clinical evidence review. This platform simplifies the analysis and reporting of genetic sequence data for clinical laboratory professionals. Velsera partners with life science and clinical diagnostic companies to deliver technology that aids in the development of new drugs and diagnostics, particularly for genetic diseases like cancer.

Key Metrics

Total Employees
XXXX
Total number of employees
Engineering
XX
Number of employees in the engineering department
Sales Team
$XX
Number of employees in the sales department
Marketing
XX
Number of employees in the marketing department
Founded
XXXX
Year the company was founded
Revenue
$XXX,XXX,XXX
Total revenue of the company
Total Funding
$XXX M
Total funding of the company
Market Cap
$XXX,XXX
Market cap of the company

Get Complete Company Metrics

Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.

Start For Free

Contact

Company
Velsera
Headquarters
Schrafft’s City Center 529 Main St, Suite 6610, Charlestown, MA 02129, US
Founded
2023
Industry
research

Technology Stack

Analytics & Tracking

Google Tag Manager

Social & Marketing

Linkedin Marketing Solutions

Database & Backend

MongoDB

Cloud & Infrastructure

CloudFlare Hosting

Productivity

Not found

Compare similar companies to Velsera

Compare insights from companies similar to Velsera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company NameRevenueNo. of EmployeesTypeFundingFounded InTop Executive
xxxxxxxx
$7268035Private-4138
xxxxx
xxxxxxxxxx
$5617516Private-1956
xxxxxxxxx
xxxxxxxxx
$354652Private-7688
xxxxxxx
xx
$2427961Private-9738
xxxxxxx
x
$5226394Private-8042
xxx

Discover Similar Companies Instantly

Explore detailed insights and analysis on companies related to your search.

Start For Free

Turn this profile into a pipeline

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free